Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11160474rdf:typepubmed:Citationlld:pubmed
pubmed-article:11160474lifeskim:mentionsumls-concept:C0030567lld:lifeskim
pubmed-article:11160474lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:11160474lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:11160474lifeskim:mentionsumls-concept:C0026456lld:lifeskim
pubmed-article:11160474lifeskim:mentionsumls-concept:C0070559lld:lifeskim
pubmed-article:11160474pubmed:issue2lld:pubmed
pubmed-article:11160474pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11160474pubmed:abstractTextTo evaluate the correlation between changes in platelet monoamine oxidase type B (MAO-B) activity and plasma beta-phenylethylamine (PEA) concentrations in patients with Parkinson's disease and controls.lld:pubmed
pubmed-article:11160474pubmed:languageenglld:pubmed
pubmed-article:11160474pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160474pubmed:citationSubsetIMlld:pubmed
pubmed-article:11160474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160474pubmed:statusMEDLINElld:pubmed
pubmed-article:11160474pubmed:monthFeblld:pubmed
pubmed-article:11160474pubmed:issn0022-3050lld:pubmed
pubmed-article:11160474pubmed:authorpubmed-author:MiuraYYlld:pubmed
pubmed-article:11160474pubmed:authorpubmed-author:YamadaSSlld:pubmed
pubmed-article:11160474pubmed:authorpubmed-author:ShojiHHlld:pubmed
pubmed-article:11160474pubmed:authorpubmed-author:ZhouGGlld:pubmed
pubmed-article:11160474pubmed:authorpubmed-author:MatsuishiTTlld:pubmed
pubmed-article:11160474pubmed:issnTypePrintlld:pubmed
pubmed-article:11160474pubmed:volume70lld:pubmed
pubmed-article:11160474pubmed:ownerNLMlld:pubmed
pubmed-article:11160474pubmed:authorsCompleteYlld:pubmed
pubmed-article:11160474pubmed:pagination229-31lld:pubmed
pubmed-article:11160474pubmed:dateRevised2008-11-20lld:pubmed
pubmed-article:11160474pubmed:meshHeadingpubmed-meshheading:11160474...lld:pubmed
pubmed-article:11160474pubmed:meshHeadingpubmed-meshheading:11160474...lld:pubmed
pubmed-article:11160474pubmed:meshHeadingpubmed-meshheading:11160474...lld:pubmed
pubmed-article:11160474pubmed:meshHeadingpubmed-meshheading:11160474...lld:pubmed
pubmed-article:11160474pubmed:meshHeadingpubmed-meshheading:11160474...lld:pubmed
pubmed-article:11160474pubmed:meshHeadingpubmed-meshheading:11160474...lld:pubmed
pubmed-article:11160474pubmed:meshHeadingpubmed-meshheading:11160474...lld:pubmed
pubmed-article:11160474pubmed:meshHeadingpubmed-meshheading:11160474...lld:pubmed
pubmed-article:11160474pubmed:meshHeadingpubmed-meshheading:11160474...lld:pubmed
pubmed-article:11160474pubmed:meshHeadingpubmed-meshheading:11160474...lld:pubmed
pubmed-article:11160474pubmed:year2001lld:pubmed
pubmed-article:11160474pubmed:articleTitlePlatelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson's disease.lld:pubmed
pubmed-article:11160474pubmed:affiliationFirst Department (Neurology) of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.lld:pubmed
pubmed-article:11160474pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160474lld:pubmed